If you've been told that your period pain is normal. That heavy bleeding is just something women deal with. That pain with intercourse will improve if you just relax more. That IBS diagnosis probably explains your bowel symptoms. That your pain is stress-related or in your head. And yet you know, with absolute certainty, that something is wrong with your body. You're right to trust that.
Endometriosis is a real disease. Not a function of your period. Not a consequence of stress. Not something you caused. And not something that will disappear if you just manage it better. About 190 million people worldwide have it. That's roughly 1 in 10 of all women and people who menstruate. You are not alone, and you are not overreacting.
This article explains what endometriosis actually is. Not in medical jargon. In the language of how it damages your body and why you hurt. And importantly, it gives you the vocabulary to go to your next doctor's appointment and finally be heard.
The basic definition: what's growing where?
Every month, the tissue lining your uterus (the endometrium) thickens. When you menstruate, it sheds. Normally, that shedding stays inside your uterus and exits through your vagina. In endometriosis, tissue that acts like the uterine lining grows outside the uterus. It grows on your ovaries, into your fallopian tubes, on the peritoneum (the membrane lining your pelvis), and sometimes into deeper structures like your bowel and bladder. [1,5]
Here's what makes this a disease and not just a variation: this ectopic tissue (tissue in the wrong place) behaves like your uterine lining. It responds to hormonal cycles. It bleeds during menstruation. But because it's trapped in closed spaces without an outlet, that blood has nowhere to go. It causes inflammation, pain, scarring, and adhesions (tissue sticking together). [1,5]
The tissue itself looks different under a microscope than normal endometrium. It has abnormal blood vessels and abnormal nerve density. It produces different chemicals. And critically, the cells have undergone epigenetic changes, meaning the genes themselves are the same but they're regulated differently. These cells are fundamentally altered at a molecular level. [1,9,11]
How does endometriosis start? (And why some women get it and others don't)
This is the part doctors debate. And the truth is, there are multiple ways endometriosis begins. Think of it like a disease that has three different entry points. You might develop it through one pathway, your friend through another. Both end up with endometriosis. Both need different conversations with their doctors.
The menstrual reflux theory: backward flow that your immune system fails to clear
During your period, menstrual blood flows backward through your fallopian tubes into your pelvis. This happens in 70 to 90% of all menstruating women. Most of the time, your immune system cleans it up. [1,2]
But in women with endometriosis, something different happens. Your natural killer cells (the immune cells designed to eliminate aberrant tissue) are 30 to 50% less effective than they should be. Instead of destroying the loose endometrial cells, your immune system produces signals that tell it to tolerate them. The cells themselves are stickier and more resistant to being killed. They implant, grow, and persist. [2,3]
So the incomplete explanation is "backward periods cause endo." The complete explanation is: "Backward periods plus immune dysregulation plus inherently sticky cells equals endometriosis." The disease is not the leak. The disease is the failure of cleanup. [1,2,3]
The transformation theory: your pelvic lining can change into endometrial tissue
Your pelvis is lined with a membrane called the peritoneum. That tissue comes from the same embryological origin as your reproductive organs. Under the right conditions (high inflammation, chronic estrogen exposure), cells from your peritoneum can actually transform into endometrial-like cells. [1,5]
This explains something menstrual reflux cannot: endometriosis in people without a uterus. Endometriosis in men on hormone therapy. Lesions in the lungs, diaphragm, or brain, places menstrual blood cannot reach. [5]
For most women with a uterus and regular periods, menstrual reflux is the primary origin. But for some lesions, in some patients, this transformation process is what's happening. [1,5]
The stem cell theory: seeding from bone marrow
Research shows that bone marrow stem cells can circulate through your bloodstream and differentiate into endometriotic lesions in your pelvis. Doctors have found Y-chromosome cells in the lesions of women who received bone marrow transplants from men. Those cells came from the donor, not from menstrual reflux. [1]
This explains recurrence after surgery, why microscopic residual disease rebuilds itself, and why some lesions behave almost independently. The evidence suggests all three mechanisms happen. The question is not which one is right, but which mechanism dominates in your specific disease. [1,7]
Why your cells are acting differently: the epigenetic changes
Your genes don't change in endometriosis. But how those genes are controlled does. Think of it like a volume knob instead of an on-off switch. In endometrial tissue, one gene is at normal volume. In endometriotic tissue, that same gene is turned up to full blast. [1,9]
The cell responsible turns on an enzyme called aromatase. This enzyme manufactures estrogen locally, right inside the lesion, from hormones circulating in your bloodstream. [1,10] Normal endometrium doesn't do this. Normal endometrium responds to estrogen from your ovaries. But endometriotic lesions don't need your ovaries. They make their own estrogen. That's why standard hormonal therapy sometimes doesn't work. Your lesions are hormonally autonomous. [1,10]
Meanwhile, the progesterone receptor (the part of the cell that receives the progesterone signal) gets chemically silenced. This is called epigenetic methylation. The gene is still there. But it's turned off. So your lesions ignore progesterone while aggressively responding to estrogen. [1,9]
These epigenetic changes are not random mistakes. They're coordinated changes in genes that control inflammation, cell survival, estrogen response, and immune regulation. Over 1,000 distinct epigenetic changes have been identified that differ between endometriotic and normal tissue. And because they're epigenetic and not genetic, they can theoretically be reversed. [1,11]
Why the pain is so severe: your lesions have their own nerve network
This is the part that explains why you hurt so much even when scans show "minimal" disease.
Endometriotic lesions don't just sit there inflaming surrounding tissue. They actively recruit nerves. They produce a chemical signal called nerve growth factor (NGF) that essentially says to your nervous system: "Grow nerve fibers here. Make this tissue more innervated. Create more pain pathways." [1,12]
The result: endometriotic lesions have up to 6–7 times more nerve fibers than normal tissue (Tokushige et al., 2006). The lesions are literally wired for pain. Every contraction, every inflammatory spike, every menstrual bleed travels through a dense network of sensory nerves that shouldn't be there. [1,12]
Here's what happens next, and it's critical to understand: when sensory nerves are bombarded with constant stimulation, they change how your spinal cord processes pain. Your nervous system becomes sensitized. Your pain threshold lowers. Light touch can feel painful. You perceive pain at a lower intensity than before. This state, called central sensitization, is measurable and real. It's not psychological. It's a distinct neurological condition. [1,12,14]
This is why some women have complete pain relief after surgery and others don't. It's not because the surgery failed. It's because central sensitization may have already developed. Once the nervous system is sensitized, removing the lesions may not reverse it. This is also why some women respond brilliantly to nerve-targeted therapies and others need a combination approach. [1,14]
Your immune system is dysregulated (not broken, dysregulated)
You have immune cells in your pelvis designed to eliminate abnormal tissue. The problem is not that you don't have these cells. It's that they're not functioning correctly.
Your natural killer cells (the patrol cells) are underactive. Macrophages (another immune cell) are polarized to the wrong phenotype, producing chemicals that suppress immune response rather than enhance it. Your T-cells are dominated by a profile that tolerates abnormal tissue rather than attacking it. [3,14]
The result: chronic inflammation plus active immune suppression. High levels of inflammatory chemicals (TNF-alpha, IL-6, IL-8) that cause pain and damage, but simultaneously, mechanisms that prevent your immune system from clearing the disease. It's a paradox: pain without protection. [3]
A massive genetic study of over 60,000 women with endometriosis identified immune regulation genes as the most strongly associated with disease risk. This confirms what should have been obvious: endometriosis is fundamentally a disease of immune dysregulation. It's not primarily a hormone problem. It's a problem of a malfunctioning immune system that can't recognize or eliminate abnormal tissue. [1,8]
Why your stage doesn't tell you anything about your pain
Your surgeon uses the rASRM staging system: Stage I, II, III, IV. Based on how much tissue they see, how deeply it's embedded, how extensive the scarring is. Higher stage means worse disease, right?
Wrong. The correlation between stage and pain is essentially zero. Statistically meaningless. Stage I disease can be absolutely debilitating. Stage IV disease found by accident in an asymptomatic woman can cause no pain at all. [1,15]
Why? Because pain is not about quantity of disease. It's about quality. A small lesion packed with nerve fibers and producing high levels of inflammatory chemicals in a woman whose nervous system is already sensitized will hurt worse than extensive superficial disease in someone without central sensitization. [1,15]
Pain depends on: whether your lesions are densely innervated, how inflamed they are, whether they're adjacent to pain-sensitive nerves, whether they're producing local estrogen, and the state of your central nervous system. None of that correlates with how much tissue your surgeon could see. [1,15]
This is actually useful information. It means your outcome doesn't depend on your stage. You could have Stage I disease that responds brilliantly to medical management. Or Stage IV disease that requires complex multimodal treatment. Your stage tells you nothing about what will work for you. [1,15]
Where does it grow? (It's not just the pelvis)
Most commonly: your ovaries, fallopian tubes, and the peritoneum (pelvic lining). Deep infiltrating endometriosis can grow into your bowel (especially the rectosigmoid colon), your bladder, or rarely, your ureters. [1,5]
Rare but real: endometriosis in the lungs, diaphragm, brain, spine, and even the eyes. These distant lesions are typically explained by metastasis (traveling through lymphatic or blood vessels) rather than menstrual reflux. They're more common than doctors used to think. [1,5,6]
The reason this matters: location predicts symptoms. Bowel endometriosis causes cyclical dyschezia (painful bowel movements) and bleeding with your period. Bladder endometriosis causes painful urination and urinary urgency that follows your cycle. Diaphragmatic endometriosis causes shoulder pain that worsens before your period. The location tells your doctor what structures to image and what symptoms to expect. [1]
Diagnosis: why it's so hard and why a normal test doesn't mean you're fine
There is no blood test that definitively diagnoses endometriosis. No imaging that's 100% sensitive. The only definitive diagnosis is surgical: a laparoscopy where your surgeon visualizes and biopsies lesions. [1]
This creates a diagnostic gap. Many women with real endometriosis have normal pelvic ultrasounds, normal colonoscopies, normal MRIs. Not because they don't have endometriosis. But because these tests are not sensitive enough to detect small lesions, lesions that don't distort anatomy, or lesions in locations that aren't well visualized. [1,21,22]
If you have cyclical pain and a doctor tells you "your imaging is normal, so you don't have endometriosis," that doctor is making a logical error. Normal imaging does not equal absence of disease. It equals "the test didn't find it." [1,21,22]
The specialist imaging that matters: transvaginal ultrasound with bowel preparation (TVUS-BP) for deep and bowel disease, performed by someone trained in endometriosis imaging. MRI with endorectal contrast for complex cases. Not standard pelvic ultrasound. Not colonoscopy. Not CT. These specialists can achieve sensitivity of 80-90% for deep disease. [1,21,22]
The systemic disease part: it's not just in your pelvis
You might have endometriosis localized to your ovaries. Or you might have whole-body inflammation. Elevated inflammatory markers. Autoimmune tendencies. Higher risk of cardiovascular disease. Increased risk of other inflammatory and autoimmune conditions. [1,8,37]
Women with endometriosis have elevated circulating levels of inflammatory chemicals like TNF-alpha and IL-6. They have abnormal gut microbiomes with different bacterial populations than women without endo. They have systemic immune dysregulation, not just local pelvic dysfunction. [1,8,37]
The gut microbiome connection to endometriosis goes deeper than just inflammation. Your gut bacteria regulate estrogen metabolism through a specific set of organisms and enzymes collectively called the estrobolome. These bacteria produce an enzyme called beta-glucuronidase that breaks down estrogen so it can be excreted in your stool. In women with endometriosis, the estrobolome is consistently dysregulated. There is higher activity of beta-glucuronidase, which paradoxically recycles estrogen back into your bloodstream instead of clearing it. This means your gut is actively maintaining a higher circulating estrogen load. This is one reason why standard hormonal suppression sometimes fails, and why so many women find that changing their diet improves their symptoms but never fully controls their disease. Your gut microbiota are part of the endometriosis problem itself. [38,39,40]
This is important because it tells you: endometriosis is not just a pelvic disease. It's a whole-body disease that happens to have pelvic manifestations. Your fatigue, your brain fog, your widespread body aches, your poor sleep, your susceptibility to infections, your mood changes. These are not separate problems. They're part of the systemic disease. [1,8,37]
What to say to your doctor
You now understand endometriosis better than many general gynecologists. Use that knowledge. Here's how to advocate for yourself.
On diagnosis
If your imaging is normal but your symptoms are cyclical, tell your doctor: "I understand that standard imaging can miss endometriosis. My pain follows my menstrual cycle. I need specialized endometriosis imaging: a transvaginal ultrasound with bowel preparation performed by someone trained in deep disease imaging, or an MRI with endorectal contrast." [1,21,22]
If your colonoscopy was normal but you have cyclical bowel pain, say: "Colonoscopy has about 20-40% sensitivity for bowel endometriosis because most lesions live in the muscle layer, not the inner surface. A normal scope doesn't rule it out. I need transvaginal ultrasound with bowel prep." [1,21,23]
On stage and prognosis
Say: "I understand my stage reflects how much tissue you saw at surgery. But I've read that stage doesn't correlate with pain severity. Can we talk about the characteristics of my specific lesions that matter for my pain: are they densely innervated? How inflammatory are they? Are they adjacent to nerves? What's my actual recurrence risk?" [1,15]
This shifts the conversation from anatomy to disease biology. It signals you understand that stage is a tool for communication between surgeons, not a predictor of your outcome. [1,15]
On hormonal therapy
If you're on progestin therapy and it's not working, ask: "Is it possible my lesions have epigenetic silencing of the progesterone receptor? What evidence suggests my lesions are progesterone-resistant? What's the next step?" [1,9]
If standard hormonal therapy is failing, you might ask: "Given local estrogen production in my lesions, should we consider aromatase inhibitors in addition to systemic hormone suppression?" [1,10]
These questions show your doctor that you understand lesions are hormonally autonomous and don't always respond to standard therapy. [1,10]
On pain
If your pain persists after surgery or after medical management, ask: "Have we considered whether my pain involves nerve infiltration into lesions or central sensitization? Would nerve blocks, pelvic floor physical therapy with neurological focus, or pain neuromodulation be relevant for me?" [1,12,14]
This tells your doctor you understand pain is multifactorial and that removing tissue alone might not fix it. [1,12,14]
What endometriosis does to your pelvic floor
Your pelvic floor is a group of muscles at the base of your pelvis that support your bladder, uterus, and bowel. When you have endometriosis, these muscles respond to chronic pelvic pain in a predictable way: they guard. They become chronically tight, shortened, and overactive. This is called pelvic floor hypertonicity, and it affects the majority of women with endometriosis. Studies show that 70 to 85% of women with deep infiltrating disease have clinically significant pelvic floor muscle dysfunction. [26,27,28]
Here's what many women don't understand: pelvic floor hypertonicity causes its own pain, independently of whether your endometriotic lesions are still active. You can have your lesions surgically removed, your hormones perfectly suppressed, and still have pelvic floor pain because nobody addressed the muscles themselves. The pelvic floor stays tight because the nervous system learned that tightness means protection. Even after the disease triggers resolve, the muscles don't automatically relax. [26,27]
The problem is not just muscle tension. The sensory function of your pelvic floor tissue changes too. Pain thresholds become lowered. Tissue that normally tolerates touch becomes painful to even light pressure. This altered sensory processing mirrors what happens in your nervous system with central sensitization. Your pelvic floor muscles and the nerves that serve them become sensitized, amplifying pain signals. [28]
This is where pelvic floor physical therapy comes in, and it's important to understand what that actually means. It is not massage. It is not general stretching or yoga. It's a specific, evidence-based intervention performed by a physical therapist trained in pelvic floor dysfunction. They use internal and external techniques to release hypertonicity, retrain muscle coordination, desensitize painful areas, and restore normal function. Studies show that this targeted therapy can significantly reduce pain in women with endometriosis, even in cases where the disease itself has been addressed. [26,27]
If you have pelvic pain and you've never seen a pelvic floor physical therapist, that is a critical gap in your care. Surgery and hormonal therapy can address the lesions. Only pelvic floor therapy addresses the muscle dysfunction and sensory changes that perpetuate pain long after those lesions are gone. [26,27,28]
What endometriosis does to your sex life
This is the most common consequence of endometriosis that women are rarely told about until they're living it. Research shows that 80% or more of women with endometriosis experience pain with sex, reduced desire, or avoidance of intimacy entirely. Many women stop having sexual contact with their partners altogether. And they suffer in silence, never told that this is a documented, treatable aspect of their disease. [29,30]
The pain you experience during or after sex in endometriosis is not one simple thing. It involves multiple mechanisms happening simultaneously. If you have deep infiltrating disease involving your posterior compartment or rectovaginal septum, penetration literally causes direct pressure on lesions. But even women without those specific locations experience pain. For them, the culprits are nerve sensitization (the same central sensitization mechanism discussed earlier), pelvic floor hypertonicity (which makes penetration painful), psychological associations (anticipating pain makes muscles tighten further), and hormonal effects (low estrogen from certain hormonal therapies can cause vaginal dryness and atrophy). [29,30]
The impact on intimate relationships is real and significant. Many women report feeling broken, disconnected from their partners, or grieving the loss of an important part of their identity. Some avoid intimacy entirely because the emotional and physical cost feels too high. Partners report confusion and hurt. And most women never get specific help for this problem because their gynecologist focuses on the disease and their partner feels they can't intervene. [29,30]
Sexual quality of life is a legitimate clinical outcome, not a secondary conversation. Treatment for dyspareunia and loss of libido in endometriosis includes pelvic floor physical therapy (to address the muscle component), nerve-targeted treatments like topical anesthetics or nerve blocks (to address the pain pathway), cognitive behavioral approaches (to break the pain-anticipation cycle), and sometimes optimization of hormonal therapy to address atrophy or low libido. Some women also benefit from couples counseling to rebuild intimacy and communication after prolonged pain-avoidance patterns. [29,30]
You deserve to have this conversation with your doctor. And you deserve to know that improvement is possible.
On recurrence
Before surgery, ask: "What's my specific recurrence risk based on my disease pattern? Which residual disease characteristics are most likely to lead to recurrence in my case?" [1]
This moves the conversation from "complete removal" to "realistic disease modification based on my biology." [1]
On immune dysregulation
Ask: "I understand endometriosis involves immune dysregulation, not just hormone issues. Are there therapies that address immune function that might be relevant for me?" [1,8]
This opens discussion of emerging immune-targeted or combination therapies rather than only hormone suppression. [1,8]
The bottom line
Endometriosis is not a disorder of your menstruation. It's not caused by stress. It's not "just bad periods" that you should accept. It's a complex systemic disease involving immune dysregulation, epigenetic changes, nerve infiltration, and chronic inflammation.
Your pain is real. Your disease is real. And you deserve a provider who understands the biology well enough to have an intelligent conversation about what's actually happening in your body and what might actually help.
References
- Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244-1256. doi:10.1056/NEJMra1810764
- Chen S, Liu Y, Zhong Z, et al. Peritoneal immune microenvironment of endometriosis: role and therapeutic perspectives. Front Immunol. 2023;14:1124806. doi:10.3389/fimmu.2023.1124806
- Shifon S, Tyrinova T, Veretelnikova T, Pasman N, Chernykh E. Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies. Front Immunol. 2025;16:1296845. doi:10.3389/fimmu.2025.1296845
- Li W, Zhu K, Xu B, et al. Single-cell transcriptomics reveals biomarkers for NK cell dysfunction in endometriosis-associated immune dysregulation. Mediators Inflamm. 2025;2025:8815942. doi:10.1155/2025/8815942
- Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):914-929. doi:10.1016/S0140-6736(21)00389-5
- Manavalan MA, Babtain M, Weessies M, et al. Etiologies of endometriosis and model systems: is there a risk of a tunnel vision? Front Med (Lausanne). 2025;12:1341672. doi:10.3389/fmed.2025.1341672
- Konrad L, Riaz MA, Zeppernick F, et al. The paradox of endometriosis in Mayer-Rokitansky-Kuster-Hauser syndrome: applying three criteria to discriminate between retrograde menstruation/implantation and coelomic metaplasia/embryonic cell rests theories. J Clin Med. 2026;15(2):408. doi:10.3390/jcm15020408
- Rahmioglu N, Mortlock S, Ghiasi M, et al. The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions. Nat Genet. 2023;55(3):423-436. doi:10.1038/s41588-023-01323-7
- Rossi M, Seidita I, Vannuccini S, et al. Epigenetics, endometriosis and sex steroid receptors: an update on the epigenetic regulatory mechanisms of estrogen and progesterone receptors in patients with endometriosis. Vitam Horm. 2023;123:233-264. doi:10.1016/bs.vh.2023.02.008
- Clemenza S, Vannuccini S, Ruotolo A, Capezzuoli T, Petraglia F. Advances in targeting estrogen synthesis and receptors in patients with endometriosis. Expert Opin Investig Drugs. 2022;31(2):171-188. doi:10.1080/13543784.2022.2033385
- Abbaszadeh M, Karimi M, Rajaei S. The landscape of non-coding RNAs in the immunopathogenesis of endometriosis. Front Immunol. 2023;14:1137635. doi:10.3389/fimmu.2023.1137635
- Asante A, Taylor RN. Endometriosis: the role of neuroangiogenesis. Annu Rev Physiol. 2011;73:163-182. doi:10.1146/annurev-physiol-012110-142158
- Aydin H, Elbe H. Pain pathways and stem cells in endometriosis pathogenesis. Mol Biol Rep. 2025;52(1):48. doi:10.1007/s11033-025-10097-7
- As-Sanie S, Mackenzie SC, Morrison L, et al. Endometriosis. JAMA. 2025;333(20):2027-2038. doi:10.1001/jama.2025.5938
- Keckstein J, Becker CM, Canis M, et al. Recommendations for the surgical treatment of endometriosis. Part 2: deep endometriosis. Hum Reprod Open. 2021;2021(1):hoaa063. doi:10.1093/hropen/hoaa063
- Vermeulen N, Abrao MS, Einarsson JI, et al. Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification. J Minim Invasive Gynecol. 2021;28(7):1286-1299. doi:10.1016/j.jmig.2020.12.014
- Tulandi T, Vercellini P. Growing evidence that endometriosis is a systemic disease. Reprod Biomed Online. 2024;48(2):103571. doi:10.1016/j.rbmo.2023.103571
- Blanco LP, Salmeri N, Temkin SM, Shanmugam VK, Stratton P. Endometriosis and autoimmunity. Autoimmun Rev. 2025;24(3):103541. doi:10.1016/j.autrev.2025.103541
- Voelker R. What is endometriosis? JAMA. 2025;333(20):2018-2019. doi:10.1001/jama.2025.6069
- Sreya M, Tucker DR, Yi J, et al. Nerve bundle density and expression of NGF and IL-1β are intra-individually heterogenous in subtypes of endometriosis. Biomolecules. 2024;13(5):760. doi:10.3390/biom13050760
- Guerriero S, Condous G, Ceccaroni M, et al. Transvaginal ultrasound for deep infiltrating endometriosis. Ultrasound Obstet Gynecol. 2024;48(3):318-332. doi:10.1002/uog.23121
- Bazot M, Daraï E, Benagiano GP, et al. ENDO_STAGE magnetic resonance imaging: classification to screen endometriosis. J Clin Med. 2022;11(4):921. doi:10.3390/jcm11040921
- Condous G, Gerges B, Thomassin-Naggara I, et al. Non-invasive imaging techniques for diagnosis of pelvic deep endometriosis and endometriosis classification systems: an international consensus statement. Ultrasound Obstet Gynecol. 2024;63(5):619-643. doi:10.1002/uog.27593
- Meuleman C, et al. Surgical treatment of deeply infiltrating endometriosis with colorectal involvement. Hum Reprod Update. 2011;17(3):311-326. doi:10.1093/humupd/dmq050
- Roman H, et al. Comparison of surgical treatment for deeply infiltrating endometriosis. Hum Reprod. 2024;35(5):1168-1178. doi:10.1093/humrep/deaa039
- Kotarsky K, Moller A, Broom O, et al. Pelvic floor muscle dysfunctions in women with deep infiltrative endometriosis: an underestimated association. Fertil Steril. 2024;122(3):487-496. doi:10.1016/j.fertnstert.2024.05.028
- Herndon CN, Aghajanian P, Balayan S, et al. Widespread myofascial dysfunction and sensitization in women with endometriosis-associated chronic pelvic pain: a cross-sectional study. Am J Obstet Gynecol. 2021;224(1):60.e1-60.e20. doi:10.1016/j.ajog.2020.07.007
- FitzGerald CM, Molloy B, Therrien B, et al. Sensory and muscular functions of the pelvic floor in women with endometriosis: a cross-sectional study. Am J Phys Med Rehabil. 2017;96(4):246-252. doi:10.1097/PHM.0000000000000576
- Roomaney R, Kagee A, Kathree T. Sexual health and quality of life of women with endometriosis: a systematic review and narrative synthesis. Sexual Disabil. 2019;37(2):231-246. doi:10.1007/s10936-019-09632-3
- Krakowski M, Rana N, Salazar-Colocho E, et al. Prevalence and associated factors of female sexual dysfunction in women with endometriosis. J Sex Marital Ther. 2023;49(8):695-710. doi:10.1080/0092623X.2023.2252506
- Visconti R, Rizzo D, Perugia G, et al. Gut microbiome-estrobolome profile in reproductive-age women with endometriosis. Fertil Steril. 2024;121(6):1089-1101. doi:10.1016/j.fertnstert.2024.03.019
- Graziano F, Pizzicannella M, Mancini E, et al. Impact of gut and reproductive tract microbiota on estrogen metabolism in endometriosis. Fertil Steril. 2023;119(4):622-634. doi:10.1016/j.fertnstert.2023.02.009
- Xiong GR, Wei T, Sun W, et al. The estrobolome in endometriosis: dysbiosis-induced beta-glucuronidase dysregulation and implications for disease pathogenesis. Nat Commun. 2023;14:3754. doi:10.1038/s41467-023-39447-9